| Literature DB >> 933411 |
W E Walker, R C Levy, I B Hanenson.
Abstract
Physostigmine salicylate, a cholinesterase inhibitor, has been shown to reverse the effects of certain drugs with anticholinergic properties. The paper provides a brief historical account of physostigmine, reviews the cholinergic drugs and their effects and suggests a management protocol based on physiologic criteria. Twenty-six overdose cases, recently treated with physostigmine, are summarized. The controversy regarding the etiology of seizures following physostigmine administration is discussed.Entities:
Mesh:
Substances:
Year: 1976 PMID: 933411 DOI: 10.1016/s0361-1124(76)80253-5
Source DB: PubMed Journal: JACEP ISSN: 0361-1124